The Department of Ocular Fundus Diseases at The Second Norman Bethune Hospital of Jilin University is located in the Yatai Campus of the hospital. It currently consists of three treatment units, with 108 open beds. Professor Liu Zaoxia serves as the director of the department, which has 19 doctors and 32 nurses. Among the medical staff, there are 9 senior and 5 associate senior titles, all of whom have overseas study or domestic training experience and hold medical doctoral degrees. The department includes 1 doctoral supervisor and 12 master's supervisors. In the nursing team, there are 2 associate senior titles and 10 head nurses.

The department was the first in Jilin Province to adopt vitrectomy technology and is equipped with internationally advanced surgical instruments such as vitrectomy systems, Zeiss microscopes, and intraocular laser machines. As a specialized ocular fundus department, it primarily employs surgical interventions combined with fundus laser therapy to treat various conditions, including vitreous hemorrhage, complex retinal detachment, proliferative vitreoretinopathy, diabetic retinopathy, severe ocular trauma, and macular diseases.

The department continuously introduces new technologies and treatments, achieving high success rates in diagnosing and managing complex and challenging cases, thereby restoring vision to many patients on the verge of blindness. It has fully implemented the 25G transconjunctival sutureless minimally invasive vitrectomy system, which has become the standard for minimally invasive ocular fundus surgery. This technique offers advantages such as shorter operation time, minimal trauma, fewer complications, faster postoperative recovery, and improved patient comfort. Additionally, the department widely employs intravitreal injections of anti-VEGF drugs, effectively inhibiting neovascularization and proving particularly suitable for treating refractory neovascular ocular fundus diseases. For patients with severe proliferative diabetic retinopathy (stages V and VI), preoperative use of anti-VEGF drugs reduces intraoperative bleeding and enhances surgical safety, laying the foundation for successful operations and improving success rates. The 25G minimally invasive vitrectomy with disinfectant air intraocular tamponade for macular holes and superior retinal detachment reduces postoperative prone positioning time and recovery duration, yielding favorable outcomes. Furthermore, the 25G minimally invasive vitrectomy with modified internal limiting membrane peeling for large macular holes shortens recovery time, preserves the central macular internal limiting membrane, and improves visual prognosis. These technologies are aligned with international standards.

The department has received multiple Jilin University Medical Achievement Awards for its treatments of epiretinal membranes, macular holes with internal limiting membrane peeling, giant retinal tears, and severe proliferative diabetic retinopathy. Its research on the pathogenesis of diabetic retinopathy, proliferative vitreoretinopathy, prevention and treatment of ocular neovascular diseases, as well as the pathogenesis and genetic diagnosis of intraocular tumors, has earned several provincial and ministerial scientific research and科技进步 awards. The department has been granted 6 National Natural Science Foundation projects and has published over 200 academic papers in domestic and international journals in recent years, including more than 50 SCI papers.

All medical staff in the department are committed to a patient-centered approach, leveraging exquisite medical skills, high-quality nursing services, and a relentless entrepreneurial spirit. United in their efforts, they strive to build a top-tier ophthalmology department in China.